McDermott and Bull executive Search

Other News

RapidDeploy and PulsePoint Partner to Increase Cardiac Arrest Survivability

The third and latest RapidDeploy and PulsePoint integration provides community AED locations on RapidDeploy maps to provide telecommunicators visibility to nearby AEDs as part of the 9-1-1 workflow. AUSTIN, Texas, Oct. 26, 2021 /PRNewswire/ — Today RapidDeploy, the industry’s leading cloud-native emergency response platform, announces a new free integration with PulsePoint, a nonprofit whose […]

The American Society for Preventive Cardiology Publishes Clinical Practice Statement on Improving the Enrollment of Women and Racially/Ethnically Diverse Populations in Cardiovascular Clinical Trials

JACKSONVILLE, Fla., Oct. 26, 2021 /PRNewswire/ — The American Society for Preventive Cardiology (ASPC) has recently published a Clinical Practice Statement in the American Journal of Preventive Cardiology: Improving the Enrollment of Women and Racially/Ethnically Diverse Populations in Cardiovascular Clinical Trials. An ASPC working group was formed, chaired by Dr. Erin Michos and Dr. Keith […]

CathVision Announces First Patient Enrollments in PVISION Multicenter Clinical Study

Researchers to Examine Efficacy of Using AI Algorithm to Confirm Pulmonary Vein Isolation COPENHAGEN, Denmark and MINNETONKA, Minn., Oct. 26, 2021 /PRNewswire/ — CathVision, a medical technology company developing innovative electrophysiology solutions in EP recording technology, today announced the first patient enrollments in the PVISION multicenter clinical study. The newly launched trial will investigate the […]

Aziyo Biologics Provides Business Update and Preliminary Third Quarter 2021 Revenue Results and Announces Timing for Third Quarter 2021 Financial Results

SILVER SPRING, Md., Oct. 25, 2021 (GLOBE NEWSWIRE) — Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today announced that it was informed by Medtronic that, after conducting a thorough review of […]

Novartis delivers solid Q3 results, with strong growth in Innovative Medicines. Announces strategic review of Sandoz

Ad hoc announcement pursuant to Art. 53 LR Q3 net sales grew +5% (cc¹, +6% USD) Innovative Medicines grew +7% (cc, +8% USD) Strong performance of key growth drivers: Entresto (+44% cc), Cosentyx (+22% cc), Kesimpta (USD 109 million), Jakavi (+26% cc), Zolgensma (+28% cc), Promacta/Revolade (+18% cc) and Kisqali (+27% cc) Sandoz declined -2% (cc, -1% USD), affected by continued pricing pressures. Ex-US […]

Coreline AI Coronary Artery Calcium Solution Shows 99.2% Accuracy From a Population Study

SEOUL, South Korea–(BUSINESS WIRE)–Coreline Soft, the developer of the AI Coronary Artery Calcium (CAC) solution named AVIEW CAC, announced that its AI CAC solution showed 99.2% accuracy from a population study conducted by the Institute for Diagnostic Accuracy (iDNA), the NELSON trial team in Europe. The study verified the performance of […]

VenoStent Embarks on Clinical Trial to Improve Success Rate of Vascular Surgery Outcomes

Successful enrollment in initial feasibility trial to support future regulatory submissions and provide better outcomes for patients with end-stage renal disease HOUSTON–(BUSINESS WIRE)–VenoStent, Inc., a clinical-stage tissue engineering company developing tunable, bioabsorbable, smart polymer wraps to fundamentally transform the efficacy of the five million vascular surgeries performed each year, announces […]

Karolinska Development’s portfolio company AnaCardio strengthens its organization to facilitate clinical trial of the drug candidate AC01 in heart failure

STOCKHOLM SWEDEN – October 25, 2021. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces today that the portfolio company AnaCardio has strengthened its organization in preparation for the initiation of a phase 1b/2a study of its drug candidate AC01 in patients with heart failure. The company’s goal is to develop an […]

ScottCare Signs Distribution Agreement With Ninety One, Expands Partnership

CLEVELAND–(BUSINESS WIRE)–ScottCare Cardiovascular Solutions ( announced that it has signed an agreement with Ninety One Holding, Inc. ( to become a principal distributor for Ninety One’s cloud software platform for cardiac implanted device monitoring, effectively expanding the partnership between the two firms. Currently, ScottCare’s 24/7 remote cardiac monitoring service, Ambucor, […]

Use of a Novel, Intermittent Pneumatic Compression Device to Promote Perforator Vein Dilation in Patients with Chronic Renal Failure: The pFACT Trial

October 2021 ISSN 2152-4343 Abstract Objective. Arteriovenous fistula (AVF) creation is an important procedure for hemodialysis in chronic renal failure (CRF) patients. Recent advancements in vascular access have resulted in endovascular AVF (endoAVF) creations. EndoAVFs are less invasive and less expensive when placed. The dilation of the perforator vein pre-procedure is crucial […]